Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

CJC-1295 no DAC vs Other Peptides: Week-One Comparison

CJC-1295 no DAC 6-8 days +15-25% pulse amplitude Minimal (<5% increase) Sleep quality (inconsistent) Requires 4-6 weeks for therapeutic outcomes. Week one is baseline establishment GHRP-6 20-30 minutes +200-300% acute spike None (transient GH only) Acute hunge

This comparison does not assign a generated winner or score.

  • CJC-1295 no DAC
  • 6-8 days
  • +15-25% pulse amplitude
  • Minimal (<5% increase)
  • Sleep quality (inconsistent)
  • Requires 4-6 weeks for therapeutic outcomes. Week one is baseline establishment
  • GHRP-6
  • 20-30 minutes
  • +200-300% acute spike
  • None (transient GH only)
  • Acute hunger within 30 min
  • Immediate GH response but no sustained elevation. Requires multiple daily dosing
  • Ipamorelin
  • 2-3 hours
  • +150-200% pulse
  • Minimal
  • Mild appetite suppression
  • Faster clearance than CJC-1295 no DAC. Stacking synergizes timelines
  • MK 677
  • 24 hours
  • +50-90% sustained
  • +30-50% by week 4
  • Increased appetite, water retention
  • Non-peptide ghrelin mimetic with faster IGF-1 response but more side effects
More references

Related material